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PURPOSE

BACKGROUND
• Transitions of care from the inpatient to outpatient
setting is an area of great opportunity for improving
patient outcomes.
• One prospective cohort study found that 20% of
patients discharged from the hospital to home
experienced an adverse event within 3 weeks of
discharge. Of these adverse events, 66% were
medication related.1
• Another observational study found that 14% of
patients had medication discrepancies at
discharge, and that readmission rates were
significantly higher in these cases.2,3
• Currently, patients receiving care at our medical
group are reviewed by a clinical pharmacist
following hospital discharge if the reason for
hospitalization is, or medications were changed for
treatment of:
• Congestive Heart failure
• Osteoporosis/fragility fracture
• Diabetes on insulin
• Anticoagulation
• Patient confusion with medications or
difficulty taking/obtaining them
• Anecdotally our group has reported many resolved
medication issues and avoided medication adverse
events since this system was implemented,
although these interventions have not been
formally quantified.
• There is not currently a standardized process
clinical pharmacists use to review medications
upon hospital discharge.

METHODS (CONTINUED)

RESULTS
Pre-Intervention: 204 Consults
Post-Intervention: 45 Consults (78% used updated EPIC smart phrases)
Primary Outcome: Interventions per Transitions of Care Consult

Interventions Reccomended per
Consult

The purpose of this project is to improve clinical
outcomes in patients transitioning from inpatient
to outpatient care by optimizing the process that
primary care pharmacists use to perform
comprehensive medication reviews.
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p<0.001

DISCUSSION
Pre‐Intervention

Post‐Intervention

Proportion of Recommendations Implemented
Post‐Intervention
Pre‐Intervention

14%

71%

NEXT STEPS

86%

METHODS

Exclusion Criteria:
• None
Primary Endpoint:
• The number of interventions/recommendations
provided by clinical pharmacists to primary care
providers per transitions of care consult
Secondary Endpoints:
• The time taken by clinical pharmacists to
complete transitions of care consults
• Proportion of clinical pharmacist
recommendations that are implemented
• 30-day re-hospitalization rates.

Pharmacist Time per Transitions of Care Consult
40
Minutes per Completed Consult

Inclusion Criteria:
• All transitions of care consults completed by
clinical pharmacists
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These results suggest that a standardized review
process conducted via EPIC smart phrases
increases interventions provided via clinical
pharmacy review during transitions of care.
Several important confounding factors such as
seasonal/staffing variation and the unblinded
nature of this study must be considered when
interpreting study results.

29%

• Results from a retrospective chart review and a
clinical pharmacist satisfaction survey were
utilized to standardize and optimize our
transitions of care review process.

• Results of the initial review (August and
September 2021) and survey were utilized
to make improvements to transitions of care
review process.
• Interventions implemented thus far include:
• Development of EPIC smart
phrases to standardize pharmacist
review process.
• Meeting with the Clinical Support
Coordinator team to review
strategies to optimize referrals to
clinical pharmacy.
• A second retrospective chart
review was completed 1 month after the
updated EPIC smart phrases were implemented
(April 2021) to determine the impact on
recommended interventions and time spent per
pharmacist consult.

p=0.22
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Additional Data Collection:
• One more month of data will be added to the
evidence summarized here to allow 2 months of
pre and post data.
• 30-day readmission rates post-intervention will
be evaluated when 30 days have passed from
the data collection period. This will allow for
determination of increased interventions or
readmission rates.
Continued Process Improvement Possibilities:
• Adjusting criteria for PharmD review
• Leverage clinical pharmacy team to continue
modifying and improving recently created EPIC
smart phrases
• Continued collaboration with Clinical Support
Coordinator team to ensure appropriate referrals
for pharmacist review.

REFERENCES

20

1. Forster AJ, Murff HJ, Peterson JF, et al. The incidence and
severity of adverse events affecting patients after discharge
from the hospital. Ann Intern Med. 2003;138(3):161–167.

15

2. Coleman EA, Smith JD, Raha D, Min SJ. Posthospital
medication discrepancies: prevalence and contributing
factors. Arch Intern Med. 2005; 165(16):1842–1847.

10
5
0
Pre‐Intervention

Post‐Intervention

3. Rau J. New Round of Medicare Readmission Penalties Hits
2,583 Hospitals. Kaiser Health News. October 1, 2019.
Accessed September 29,
2020. https://guides.himmelfarb.gwu.edu/AMA/websites

